Ocular Therapeutix, Inc.

OCUL Nasdaq SEC CIK 1393434
Follow Ocular Therapeutix Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $12.9M −11.5% vs same quarter last year
Net income −$94.8M −36.5% vs same quarter last year
EPS, diluted −$0.42 −10.5% vs same quarter last year
Operating cash flow −$65.6M −29.4% vs same quarter last year
Revenue by quarter
$17.1M
$10.7M
$13.5M
$14.5M
$13.3M
$10.8M
$13.5M
$12.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$52M−$265.9M
FY24$63.7M−$193.5M
FY23$58.4M−$80.7M
FY22$51.5M−$71M
FY21$43.5M−$6.6M
FY20$17.4M−$155.6M
FY19$4.2M−$86.4M
FY18$2M−$60M
FY17$1.9M−$63.4M
FY16$1.9M−$44.7M
FY15$1.8M−$39.7M
FY14$772K−$28.6M
FY13-−$13.3M
FY12$10K−$14.1M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150000%−100000%−50000%0%50000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2587.3%−519.8%−511.9%
FY2491.2%−269.6%−303.7%
FY2391%−141%−138.1%
FY2291.2%−152.7%−138%
FY2189.9%−179.3%−15.1%
FY2088%−361.1%−894.3%
FY1945%−2029.9%−2043.3%
FY1876.6%−2970.8%−3014%
FY1776.2%−3220.1%−3296.2%
FY1676.5%−2296%−2369%
FY1581.8%−2182.7%−2271.3%
FY1488.2%−3509.6%−3710.9%
FY13---
FY1230%−136710%−140930%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$216.9M
FY24−$136M
FY23−$76.3M
FY22−$63.3M
FY21−$66.7M
FY20−$54.4M
FY19−$79.8M
FY18−$51.1M
FY17−$58.7M
FY16−$35.9M
FY15−$35.5M
FY14−$21.8M
FY13−$13M
FY12−$12.8M
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Ocular Therapeutix
  • Healthcare median
−150000%−100000%−50000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOcular TherapeutixHealthcare median
FY25−511.9%−30.6%
FY24−303.7%−47%
FY23−138.1%−58%
FY22−138%−80.4%
FY21−15.1%−71.9%
FY20−894.3%−62.2%
FY19−2043.3%−46.3%
FY18−3014%−49.6%
FY17−3296.2%−45.9%
FY16−2369%−36%
FY15−2271.3%−38.4%
FY14−3710.9%−35.5%
FY13-−37.1%
FY12−140930%−29.1%
FY11-−27.9%